Mark
It is great to see some on this thread are open to finding out how things in the real world of drug development operate and not just dismiss a view that one has posted because it does not give the counterparty warm and fuzzy feelings and maybe inconsistent with what they continue to espouse on this thread.
good work, well done and thank you
PS..I dont need an apologies but thanks for going into bat for a bit of rationality on this thread...I must also go and read some of decan's posts as he sure has stirred up some feeling from a few posters over on the GBI thread as well as this one!
patient numbers required for clinical study , page-18
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
0.015(4.41%) |
Mkt cap ! $515.6M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 36.0¢ | 34.0¢ | $1.270M | 3.611M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 286261 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 253490 | 7 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |